Abstract
ObjectiveClinical diagnosis and approval of new medications for non-alcoholic steatohepatitis (NASH) require invasive liver biopsies. The aim of our study was to identify non-invasive biomarkers of NASH and/or liver fibrosis.DesignThis...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have